Post-prostatic-massage urine exosomes of men with chronic prostatitis/chronic pelvic pain syndrome carry prostate-cancer-typical microRNAs and activate proto-oncogenes.


Journal

Molecular oncology
ISSN: 1878-0261
Titre abrégé: Mol Oncol
Pays: United States
ID NLM: 101308230

Informations de publication

Date de publication:
03 2023
Historique:
revised: 05 10 2022
received: 22 06 2022
accepted: 31 10 2022
pubmed: 3 11 2022
medline: 7 3 2023
entrez: 2 11 2022
Statut: ppublish

Résumé

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has a high prevalence of up to 15% and accounts for 90-95% of prostatitis diagnoses, and yet its etiopathogenesis and link to prostate cancer (PCa) are still unclear. Here, we investigated microRNAs in exosomes isolated from blood and post-prostatic-massage urine of CP/CPPS type IIIb patients and healthy men. THP-1 monocytes (human leukemia monocytic cell line) were treated with exosomes and subjected to mRNA arrays "Cancer Inflammation and Immunity Crosstalk" and "Transcription Factors." Using The Cancer Genome Atlas, the expression of CP/CPPS-associated microRNAs was analyzed in PCa and normal prostate tissue. In silico functional studies were carried out to explore the disease ontology of CP/CPPS. In CP/CPPS, urine exosomes exhibited significant upregulation of eight PCa-specific microRNAs (e.g., hsa-miR-501, hsa-miR-20a, and hsa-miR-106), whose target genes were significantly enriched for GO terms, hallmark gene sets, and pathways specific for carcinogenesis. In THP-1 monocytes, CP/CPPS-derived urine exosomes induced upregulation of PCa-associated proinflammatory genes (e.g., CCR2 and TLR2) and proto-oncogene transcription factors (e.g., MYB and JUNB). In contrast, CP/CPPS-derived blood exosomes exhibited molecular properties similar to those of healthy men. Thus, CP/CPPS exhibits molecular changes that constitute a risk for PCa and should be considered in the development of PCa biomarkers and cancer screening programs.

Identifiants

pubmed: 36321189
doi: 10.1002/1878-0261.13329
pmc: PMC9980307
doi:

Substances chimiques

MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

445-468

Informations de copyright

© 2022 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Références

Med Hypotheses. 2009 Mar;72(3):261-2
pubmed: 19095365
Int J Mol Sci. 2021 Jul 23;22(15):
pubmed: 34360620
Eur Urol. 2016 Feb;69(2):286-97
pubmed: 26411805
Cancer Res. 2000 Feb 1;60(3):702-6
pubmed: 10676656
Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1594-1603
pubmed: 31337640
Int J Mol Sci. 2017 Jan 27;18(2):
pubmed: 28134831
Brain Behav Immun Health. 2020 Sep 25;9:100140
pubmed: 34589888
Epidemiology. 2004 Jan;15(1):93-9
pubmed: 14712152
Cell Mol Biol Lett. 2021 May 22;26(1):20
pubmed: 34022794
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Drugs Aging. 2003;20(15):1111-25
pubmed: 14651434
RNA Biol. 2021 Nov;18(11):2038-2053
pubmed: 33944671
Cell Commun Signal. 2020 May 29;18(1):82
pubmed: 32471499
Int J Mol Sci. 2013 Jul 09;14(7):14240-69
pubmed: 23839094
Arch Ital Urol Androl. 2017 Dec 31;89(4):259-265
pubmed: 29473374
Transl Androl Urol. 2021 Aug;10(8):3340-3347
pubmed: 34532258
Indian J Urol. 2011 Jan;27(1):14-8
pubmed: 21716879
J Nutr Biochem. 2013 Jan;24(1):289-97
pubmed: 22902331
Cancers (Basel). 2019 Dec 21;12(1):
pubmed: 31877768
J Cell Biochem. 2004 Jan 1;91(1):13-25
pubmed: 14689577
Cell Death Differ. 2015 Apr;22(4):574-82
pubmed: 25526087
Int J Cancer. 2011 Feb 1;128(3):608-16
pubmed: 20473869
Histopathology. 2012 Jan;60(1):199-215
pubmed: 22212087
J Urol. 2002 Aug;168(2):593-8
pubmed: 12131316
Urology. 2009 Mar;73(3):538-42; discussion 542-3
pubmed: 19118880
Eur Rev Med Pharmacol Sci. 2017 Feb;21(4):715-722
pubmed: 28272712
BMC Cancer. 2012 Mar 23;12:111
pubmed: 22439757
Nat Rev Urol. 2018 Jan;15(1):11-24
pubmed: 29089606
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
PLoS One. 2012;7(10):e46737
pubmed: 23091600
Nat Rev Urol. 2014 May;11(5):259-69
pubmed: 24686526
Immunol Cell Biol. 2019 Feb;97(2):178-189
pubmed: 30252968
J Urol. 2010 Dec;184(6):2339-45
pubmed: 20952019
Cancer Metastasis Rev. 2010 Dec;29(4):709-22
pubmed: 20839032
J Circ Biomark. 2022 Feb 10;11:5-13
pubmed: 35173821
Fundam Clin Pharmacol. 2020 Apr;34(2):160-172
pubmed: 31642541
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Br J Cancer. 2022 May;126(8):1205-1214
pubmed: 34837075
Cancer Res. 2017 Sep 15;77(18):5158-5168
pubmed: 28687617
PLoS One. 2013 Dec 31;8(12):e82589
pubmed: 24391718
JAMA. 1999 Jul 21;282(3):236-7
pubmed: 10422990
Cell Adh Migr. 2021 Dec;15(1):180-201
pubmed: 34157951
Clin Chim Acta. 2020 Jan;500:226-232
pubmed: 31678573
Cancers (Basel). 2021 Aug 14;13(16):
pubmed: 34439249
Int J Oncol. 2020 Apr;56(4):957-968
pubmed: 32319557
BJU Int. 2005 Sep;96(4):559-65
pubmed: 16104910
Clin Exp Immunol. 2002 May;128(2):302-7
pubmed: 12041509
Eur Urol. 2013 May;63(5):953-9
pubmed: 23141933
Exp Ther Med. 2015 Mar;9(3):658-666
pubmed: 25667610
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Eur Urol. 2011 Jul;60(1):106-17
pubmed: 21497433
Bioinformatics. 2015 Feb 15;31(4):608-9
pubmed: 25677125
Oncogene. 2015 Sep 17;34(38):4975-84
pubmed: 25531328
Oncotarget. 2018 Apr 13;9(28):19623-19639
pubmed: 29731970
Pharmgenomics Pers Med. 2022 Mar 10;15:177-193
pubmed: 35300057
J Urol. 2002 Sep;168(3):1048-53
pubmed: 12187220
Mol Cell Oncol. 2015 Feb 03;3(1):e1010948
pubmed: 27308526
Med Oncol. 2013 Mar;30(1):353
pubmed: 23263848
Sci Adv. 2016 May 27;2(5):e1600200
pubmed: 27386546
Biomed Res Int. 2014;2014:230183
pubmed: 25197632
Urol Int. 2017;98(1):89-101
pubmed: 27760433

Auteurs

Laura Schneider (L)

Clinic of Urology, Pediatric Urology and Andrology, Justus-Liebig-University Giessen, Germany.
Working Group "Epigenetics of the Urogenital System," Clinic of Urology, Pediatric Urology and Andrology, Justus-Liebig-University Giessen, Germany.

Temuujin Dansranjav (T)

Clinic of Urology, Pediatric Urology and Andrology, Justus-Liebig-University Giessen, Germany.

Elena Neumann (E)

Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University of Giessen, Bad Nauheim, Germany.

Hang Yan (H)

Clinic of Urology, Pediatric Urology and Andrology, Justus-Liebig-University Giessen, Germany.
Working Group "Epigenetics of the Urogenital System," Clinic of Urology, Pediatric Urology and Andrology, Justus-Liebig-University Giessen, Germany.

Adrian Pilatz (A)

Clinic of Urology, Pediatric Urology and Andrology, Justus-Liebig-University Giessen, Germany.

Hans-Christian Schuppe (HC)

Clinic of Urology, Pediatric Urology and Andrology, Justus-Liebig-University Giessen, Germany.

Florian Wagenlehner (F)

Clinic of Urology, Pediatric Urology and Andrology, Justus-Liebig-University Giessen, Germany.

Undraga Schagdarsurengin (U)

Clinic of Urology, Pediatric Urology and Andrology, Justus-Liebig-University Giessen, Germany.
Working Group "Epigenetics of the Urogenital System," Clinic of Urology, Pediatric Urology and Andrology, Justus-Liebig-University Giessen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH